IDXX Q2 2025 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

Q2 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.1B+10.6% YoY

Gross Profit

$695M62.6% margin

Operating Income

$373M33.6% margin

Net Income

$294M26.5% margin

EPS (Diluted)

$3.63

QoQ Revenue Growth

+11.1%

Cash Flow

Operating Cash Flow

$186M

Free Cash Flow

$152M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$3.3B

Total Liabilities

$1.9B

Stockholders' Equity

$1.5B

Cash & Equivalents

$165M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.0B	+10.6%
Gross Profit	$695M	$621M	+11.9%
Operating Income	$373M	$264M	+41.4%
Net Income	$294M	$203M	+44.6%

Revenue Segments

Product

$658M59%

Service

$452M41%

Geographic Segments

UNITED STATES

$718M65%

EMEA

$233M21%

Asia Pacific

$89M8%

CANADA

$47M4%

Latin America

$22M2%